This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Freedman AS, Ritz J, Neuberg D et al. Autologous bone marrow transplantation in 69 patients with a history of low-grade B-cell non-Hodgkin's lymphoma. Blood 1991; 77: 2524.
Rohatiner A, Johnson P, Price C et al. Myeloablative therapy with autologous bone marrow transplantation as consolidation therapy for recurrent follicular lymphoma. J Clin Oncol 1994; 12: 1177–1185.
Price CGA, Meerabux J, Murtagh S et al. The significance of circulating cells carrying t(14;18) in long remission from follicular lymphoma. J Clin Oncol 1991; 9: 1527.
Gribben J, Neuberg D, Freedman A et al. Detection by polymerase chain reaction of residual cells with the bcl-2 translocation is associated with increased risk of relapse after autologous bone marrow transplantation for B-cell lymphoma. Blood 1993; 81: 3449–3457.
Osorio S, de la Camara R, Golbano N et al. Progressive multifocal leukoencephalopathy after stem cell transplantation, unsuccessfully treated with cidofovir. Bone Marrow Transplant 2002; 30: 963–966.
Rutella S, Rumi C, Laurenti L . Immune reconstitution after transplantation of autologous peripheral CD34+ cells: analysis of predictive factors and comparison with unselected progenitor transplants. Br J Haematol 2000; 108: 105–115.
Storek J, Witherspoon RP . Immunologic reconstitution after hematopoietic stem cell transplantation. In: Atkinson K (ed.). Clinical Bone Marrow and Blood Stem Cell Transplantation, Vol 1, Cambridge University Press: Boston, MA, 2000, pp 111–146.
Divine M, Boutolleau D, Delfau-Larue M et al. Poor lymphocyte recovery following CD34-selected autologous peripheral blood stem cell transplantation for non-Hodgkin's lymphoma. Br J Haematol 1999; 105: 349–360.
Bomberger C, Singh-Jairam M, Rodey G . Lymphoid reconstitution after autologous PBSC transplantation with FACS-sorted CD34+ hematopoietic progenitors. Blood 1998; 91: 2588–2600.
Carreras E, Saiz A, Marin P et al. CD34+ selected autologous peripheral blood stem cell transplantation for multiple sclerosis: report of toxicity and treatment results at one year of follow-up in 15 patients. Haematologica 2003; 88: 306–314.
Acknowledgements
This study was supported by Grant FIS 95/0203 from the Fondo de Investigaciones Sanitarias from the Spanish Ministry of Health.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Cordoba, R., Arranz, R. & Cannata, J. Unexpected immune complications in patients with non-Hodgkin's lymphoma receiving CD34-selected autologous peripheral stem cell transplantation. Bone Marrow Transplant 35, 1217–1218 (2005). https://doi.org/10.1038/sj.bmt.1704977
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.bmt.1704977